SOX6
Basic information
Region (hg38): 11:15966449-16739591
Links
Phenotypes
GenCC
Source:
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Moderate), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Tolchin-Le Caignec syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 32442410 |
ClinVar
This is a list of variants' phenotypes submitted to
- Tolchin-Le Caignec syndrome (5 variants)
- not provided (4 variants)
- Inborn genetic diseases (4 variants)
- Intellectual disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOX6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 20 | ||||
missense | 65 | 11 | 86 | |||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 2 | 6 | ||
non coding | 10 | 11 | 22 | |||
Total | 11 | 11 | 68 | 37 | 18 |
Highest pathogenic variant AF is 0.00000662
Variants in SOX6
This is a list of pathogenic ClinVar variants found in the SOX6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-15972812-G-T | Uncertain significance (May 11, 2022) | |||
11-15972819-C-T | Uncertain significance (Feb 04, 2024) | |||
11-15972830-C-T | Likely benign (Jul 06, 2021) | |||
11-15972839-A-G | Benign (Sep 19, 2022) | |||
11-15972848-G-A | Likely benign (May 05, 2023) | |||
11-15972849-C-T | Inborn genetic diseases | Uncertain significance (Aug 11, 2022) | ||
11-15972851-A-G | Likely benign (Jan 26, 2022) | |||
11-15972914-C-G | Inborn genetic diseases | Likely benign (May 15, 2024) | ||
11-15972962-G-GCTCT | Uncertain significance (Aug 23, 2019) | |||
11-15972982-T-C | Uncertain significance (Aug 01, 2023) | |||
11-15972990-G-C | Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
11-15973029-G-C | SOX6-related disorder | Uncertain significance (Feb 07, 2024) | ||
11-15973072-C-T | Tolchin-Le Caignec syndrome | Uncertain significance (Apr 04, 2024) | ||
11-15986197-T-C | SOX6-related disorder | Benign/Likely benign (Jan 21, 2024) | ||
11-15986206-C-A | SOX6-related disorder | Benign (Aug 21, 2022) | ||
11-15986207-A-G | Inborn genetic diseases | Uncertain significance (Nov 30, 2022) | ||
11-15986217-A-G | Uncertain significance (Jun 15, 2022) | |||
11-15986218-C-T | Likely benign (Oct 01, 2022) | |||
11-15986218-C-CTG | Uncertain significance (Jan 10, 2024) | |||
11-15986234-C-T | Inborn genetic diseases | Uncertain significance (May 21, 2024) | ||
11-15986243-C-T | Inborn genetic diseases | Uncertain significance (Jan 05, 2023) | ||
11-15986305-C-T | Likely benign (May 15, 2022) | |||
11-15986310-G-A | Tolchin-Le Caignec syndrome | Pathogenic (Aug 30, 2024) | ||
11-15986313-G-A | Neurodevelopmental disorder | Likely pathogenic (Oct 19, 2020) | ||
11-15986347-G-A | Likely benign (Mar 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SOX6 | protein_coding | protein_coding | ENST00000396356 | 15 | 773144 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000157 | 125595 | 0 | 2 | 125597 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.93 | 339 | 455 | 0.746 | 0.0000262 | 5311 |
Missense in Polyphen | 124 | 207.55 | 0.59744 | 2358 | ||
Synonymous | 0.162 | 167 | 170 | 0.984 | 0.00000975 | 1560 |
Loss of Function | 5.48 | 4 | 42.6 | 0.0939 | 0.00000222 | 471 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000881 | 0.00000881 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator. Binds specifically to the DNA sequence 5'-AACAAT-3'. Plays a key role in several developmental processes, including neurogenesis and skeleton formation.;
- Pathway
- NOTCH1 regulation of human endothelial cell calcification;Endochondral Ossification;Signaling by WNT;Signal Transduction;Deactivation of the beta-catenin transactivating complex;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.188
Intolerance Scores
- loftool
- 0.00909
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.72
Haploinsufficiency Scores
- pHI
- 0.559
- hipred
- Y
- hipred_score
- 0.725
- ghis
- 0.574
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.372
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sox6
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; skeleton phenotype;
Zebrafish Information Network
- Gene name
- sox6
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- process quality
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;cell morphogenesis;in utero embryonic development;regulation of transcription, DNA-templated;muscle organ development;post-embryonic development;gene silencing;oligodendrocyte cell fate specification;positive regulation of chondrocyte differentiation;cell fate commitment;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;astrocyte differentiation;erythrocyte development;cartilage development;cardiac muscle cell differentiation;positive regulation of cartilage development;cellular response to transforming growth factor beta stimulus;negative regulation of cardiac muscle cell differentiation;positive regulation of mesenchymal stem cell differentiation
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;protein heterodimerization activity